Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 643

1.
2.

Utility of community-acquired pneumonia severity scores in guiding disposition from the emergency department: Intensive care or short-stay unit?

Williams JM, Greenslade JH, Chu KH, Brown AF, Lipman J.

Emerg Med Australas. 2018 Apr 2. doi: 10.1111/1742-6723.12947. [Epub ahead of print]

PMID:
29609223
3.

PHARMACOKINETICS OF INTRAVENOUS POSACONAZOLE IN CRITICALLY ILL PATIENTS.

Sime FB, Stuart J, Butler J, Starr T, Wallis SC, Pandey S, Lipman J, Roberts JA.

Antimicrob Agents Chemother. 2018 Mar 26. pii: AAC.00242-18. doi: 10.1128/AAC.00242-18. [Epub ahead of print]

4.

Individualising Therapy to Minimize Bacterial Multidrug Resistance.

Heffernan AJ, Sime FB, Lipman J, Roberts JA.

Drugs. 2018 Apr;78(6):621-641. doi: 10.1007/s40265-018-0891-9. Review.

PMID:
29569104
5.

Population pharmacokinetics of vancomycin in critically ill patients receiving prolonged intermittent renal replacement therapy.

Economou CJP, Kielstein JT, Czock D, Xie J, Field J, Richards B, Tallot M, Visser A, Koenig C, Hafer C, Schmidt JJ, Lipman J, Roberts JA.

Int J Antimicrob Agents. 2018 Mar 8. pii: S0924-8579(18)30072-4. doi: 10.1016/j.ijantimicag.2018.03.001. [Epub ahead of print]

PMID:
29526606
6.

Outcomes in Patients with Vasodilatory Shock and Renal Replacement Therapy Treated with Intravenous Angiotensin II.

Tumlin JA, Murugan R, Deane AM, Ostermann M, Busse LW, Ham KR, Kashani K, Szerlip HM, Prowle JR, Bihorac A, Finkel KW, Zarbock A, Forni LG, Lynch SJ, Jensen J, Kroll S, Chawla LS, Tidmarsh GF, Bellomo R; Angiotensin II for the Treatment of High-Output Shock 3 (ATHOS-3) Investigators.

Crit Care Med. 2018 Jun;46(6):949-957. doi: 10.1097/CCM.0000000000003092.

PMID:
29509568
7.

Pharmacokinetics of piperacillin in critically ill patients with acute kidney injury receiving sustained low-efficiency diafiltration.

Sinnollareddy MG, Roberts MS, Lipman J, Peake SL, Roberts JA.

J Antimicrob Chemother. 2018 Jun 1;73(6):1647-1650. doi: 10.1093/jac/dky057.

PMID:
29506150
8.

Optimization and Evaluation of Piperacillin-Tobramycin Combination Dosage Regimens against Pseudomonas aeruginosa for Patients with Altered Pharmacokinetics via the Hollow-Fiber Infection Model and Mechanism-Based Modeling.

Yadav R, Rogers KE, Bergen PJ, Bulitta JB, Kirkpatrick CMJ, Wallis SC, Paterson DL, Nation RL, Lipman J, Roberts JA, Landersdorfer CB.

Antimicrob Agents Chemother. 2018 Apr 26;62(5). pii: e00078-18. doi: 10.1128/AAC.00078-18. Print 2018 May.

PMID:
29463528
9.

Clinical application of microsampling versus conventional sampling techniques in the quantitative bioanalysis of antibiotics: a systematic review.

Guerra Valero YC, Wallis SC, Lipman J, Stove C, Roberts JA, Parker SL.

Bioanalysis. 2018 Mar;10(6):407-423. doi: 10.4155/bio-2017-0269. Epub 2018 Feb 16.

PMID:
29451394
10.

Differences in suppression of regrowth and resistance despite similar initial bacterial killing for meropenem and piperacillin/tazobactam against Pseudomonas aeruginosa and Escherichia coli.

Bergen PJ, Bulitta JB, Sime FB, Lipman J, McGregor MJ, Millen N, Paterson DL, Kirkpatrick CMJ, Roberts JA, Landersdorfer CB.

Diagn Microbiol Infect Dis. 2018 May;91(1):69-76. doi: 10.1016/j.diagmicrobio.2017.12.019. Epub 2018 Jan 3.

PMID:
29395712
11.

Variable Bone Density of Scaphoid: Importance of Subchondral Screw Placement.

Swanstrom MM, Morse KW, Lipman JD, Hearns KA, Carlson MG.

J Wrist Surg. 2018 Feb;7(1):66-70. doi: 10.1055/s-0037-1605381. Epub 2017 Aug 8.

PMID:
29383278
12.

Decreased darunavir concentrations during once-daily co-administration with maraviroc and raltegravir: OPTIPRIM-ANRS 147 trial.

Pressiat C, Hirt D, Treluyer JM, Zheng Y, Morlat P, Naqvi A, Tran L, Viard JP, Avettand-Fenoel V, Rouzioux C, Meyer L, Cheret A; OPTIPRIM Study Group .

J Antimicrob Chemother. 2018 Apr 1;73(4):1020-1024. doi: 10.1093/jac/dkx498.

PMID:
29365125
13.

Is augmented renal clearance the Holy Grail of antibiotic therapy failure in ventilator-acquired pneumonia?

Dahyot-Fizelier C, Marchand S, Lipman J.

Anaesth Crit Care Pain Med. 2018 Feb;37(1):5-6. doi: 10.1016/j.accpm.2017.12.003. No abstract available.

PMID:
29362162
14.

Prevalence of augmented renal clearance and performance of glomerular filtration estimates in Indigenous Australian patients requiring intensive care admission.

Tsai D, Udy AA, Stewart PC, Gourley S, Morick NM, Lipman J, Roberts JA.

Anaesth Intensive Care. 2018 Jan;46(1):42-50.

PMID:
29361255
15.

Re: 'Is a randomized trial of a short course of aminoglycoside added to β-lactam antibiotics for empirical treatment in critically ill patients with sepsis justified?' Pharmacokinetic/pharmacodynamic considerations.

Heffernan A, Lipman J, Roberts J.

Clin Microbiol Infect. 2018 Jun;24(6):666-667. doi: 10.1016/j.cmi.2017.12.019. Epub 2018 Jan 6. No abstract available.

PMID:
29309932
16.

Antimicrobial resistance and antibiotic stewardship programs in the ICU: insistence and persistence in the fight against resistance. A position statement from ESICM/ESCMID/WAAAR round table on multi-drug resistance.

De Waele JJ, Akova M, Antonelli M, Canton R, Carlet J, De Backer D, Dimopoulos G, Garnacho-Montero J, Kesecioglu J, Lipman J, Mer M, Paiva JA, Poljak M, Roberts JA, Rodriguez Bano J, Timsit JF, Zahar JR, Bassetti M.

Intensive Care Med. 2018 Feb;44(2):189-196. doi: 10.1007/s00134-017-5036-1. Epub 2017 Dec 29.

PMID:
29288367
17.

Fixed-bearing medial unicompartmental knee arthroplasty restores neither the medial pivoting behavior nor the ligament forces of the intact knee in passive flexion.

Kia M, Warth LC, Lipman JD, Wright TM, Westrich GH, Cross MB, Mayman DJ, Pearle AD, Imhauser CW.

J Orthop Res. 2017 Dec 15. doi: 10.1002/jor.23838. [Epub ahead of print]

PMID:
29244223
18.

A surgical residency preparatory course for senior medical students leads to earlier independence in ACGME competencies.

Wunder JA, Brandt CP, Lipman JM.

Am J Surg. 2018 Feb;215(2):309-314. doi: 10.1016/j.amjsurg.2017.08.052. Epub 2017 Nov 8.

PMID:
29157893
19.

Identifying "at-risk" patients for sub-optimal beta-lactam exposure in critically ill patients with severe infections.

Abdul-Aziz MH, Lipman J, Roberts JA.

Crit Care. 2017 Nov 21;21(1):283. doi: 10.1186/s13054-017-1871-2. No abstract available.

20.

Prolonged Infusion Piperacillin-Tazobactam Decreases Mortality and Improves Outcomes in Severely Ill Patients: Results of a Systematic Review and Meta-Analysis.

Rhodes NJ, Liu J, O'Donnell JN, Dulhunty JM, Abdul-Aziz MH, Berko PY, Nadler B, Lipman J, Roberts JA.

Crit Care Med. 2018 Feb;46(2):236-243. doi: 10.1097/CCM.0000000000002836.

PMID:
29116995

Supplemental Content

Loading ...
Support Center